{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:59:04Z","timestamp":1770335944532,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["1H79TI081729"],"award-info":[{"award-number":["1H79TI081729"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004925","name":"Texas Health and Human Services Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.japh.2022.10.005","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T21:42:14Z","timestamp":1665438134000},"page":"317-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A qualitative exploration of unintentional versus intentional exposure to fentanyl among people who use drugs in Austin, TX"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2797-0037","authenticated-orcid":false,"given":"Jessica","family":"Duncan Cance","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0776-2759","authenticated-orcid":false,"given":"Amanda","family":"Bingaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-9849","authenticated-orcid":false,"given":"Sara","family":"Hairgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-3457","authenticated-orcid":false,"given":"Sorina B.","family":"Torrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4962-3375","authenticated-orcid":false,"given":"Austin","family":"Buck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4636-864X","authenticated-orcid":false,"given":"Claire M.","family":"Zagorski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7969-5209","authenticated-orcid":false,"given":"Lindsey J.","family":"Loera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-0159","authenticated-orcid":false,"given":"Lucas G.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2022.10.005_bib1","author":"Ahmad"},{"key":"10.1016\/j.japh.2022.10.005_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108314","article-title":"Steep increases in fentanyl-related mortality west of the Mississippi River: recent evidence from county and state surveillance","volume":"216","author":"Shover","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2022.10.005_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: a rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.japh.2022.10.005_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugpo.2008.08.003","article-title":"Heroin in brown, black and white: structural factors and medical consequences in the US heroin market","volume":"20","author":"Ciccarone","year":"2009","journal-title":"Int J Drug Policy"},{"issue":"11","key":"10.1016\/j.japh.2022.10.005_bib5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.drugpo.2015.04.009","article-title":"Fire in the vein: heroin acidity and its proximal effect on users\u2019 health","volume":"26","author":"Ciccarone","year":"2015","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2022.10.005_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","article-title":"Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study","volume":"46","author":"Carroll","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2022.10.005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107547","article-title":"Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities","volume":"204","author":"Morales","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2022.10.005_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103467","article-title":"Consuming illicit opioids during a drug overdose epidemic: illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market","volume":"99","author":"Duhart Clarke","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2022.10.005_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","article-title":"Heroin uncertainties: exploring users\u2019 perceptions of fentanyl-adulterated and -substituted \u2018heroin","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2022.10.005_bib10","author":"Stock"},{"issue":"6","key":"10.1016\/j.japh.2022.10.005_bib11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.japh.2019.06.019","article-title":"Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm\u00a0reduction","volume":"59","author":"Hill","year":"2019","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2022.10.005_bib12","author":"Analysis"},{"key":"10.1016\/j.japh.2022.10.005_bib13","doi-asserted-by":"crossref","unstructured":"Loera LJ, Hill LG, Zagorski CM, Jermain ML, Tirado CF. Description and evaluation of a pilot advanced pharmacy practice experience in addiction medicine [e-pub ahead of print]. Am J Pharm Educ. https:\/\/doi.org\/10.5688\/ajpe8926. Accessed December 6, 2022.","DOI":"10.5688\/ajpe8926"},{"key":"10.1016\/j.japh.2022.10.005_bib14","series-title":"Qualitative Data Analysis: A Methods Sourcebook","author":"Miles","year":"2014"},{"issue":"1","key":"10.1016\/j.japh.2022.10.005_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12954-021-00478-4","article-title":"High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips","volume":"18","author":"Lockwood","year":"2021","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.japh.2022.10.005_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102939","article-title":"Isotonitazene as a contaminant of concern in the illegal opioid supply: a practical synthesis and cost perspective","volume":"86","author":"Zagorski","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.japh.2022.10.005_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3821\/145.3.cpj124","article-title":"Pharmacists and harm reduction: a review of current practices and attitudes","volume":"145","author":"Watson","year":"2012","journal-title":"Can Pharm J (Ott)"},{"issue":"3","key":"10.1016\/j.japh.2022.10.005_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1331\/JAPhA.2009.07127","article-title":"Expanding access to sterile syringes through pharmacies: assessment of New York\u2019s expanded syringe access program","volume":"49","author":"Tesoriero","year":"2009","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2022.10.005_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12954-021-00517-0","article-title":"Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study","volume":"18","author":"Parry","year":"2021","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.japh.2022.10.005_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/08897077.2021.1941516","article-title":"The gatekeepers in prevention\u201d: community pharmacist perceptions of their role in the opioid epidemic","volume":"43","author":"Vadiei","year":"2022","journal-title":"Subst Abus"},{"key":"10.1016\/j.japh.2022.10.005_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.drugpo.2019.10.004","article-title":"Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs","volume":"74","author":"Lambdin","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2022.10.005_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103128","article-title":"Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: lessons from a syringe services program in North Carolina","volume":"93","author":"Zibbell","year":"2021","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2022.10.005_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugpo.2019.05.020","article-title":"Street fentanyl use: experiences, preferences, and concordance between self-reports and urine toxicology","volume":"71","author":"Daniulaityte","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.japh.2022.10.005_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/15563650.2017.1339889","article-title":"Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose [published correction appears in Clin Toxicol (Phila). 2018;56(1):80]","volume":"56","author":"Griswold","year":"2018","journal-title":"Clin Toxicol (Phila)"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122003314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122003314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:52:33Z","timestamp":1761544353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319122003314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1544319122003314"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2022.10.005","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A qualitative exploration of unintentional versus intentional exposure to fentanyl among people who use drugs in Austin, TX","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2022.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}